tiprankstipranks
Clovis Oncology (CLVS)
NASDAQ:CLVS

Clovis Oncology (CLVS) Stock Investors

1,616 Followers
Based on 595,212 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.1% of all portfolios hold CLVS
On average, investors allocate 2.39% of their portfolios to CLVS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CLVS

1.8%
Last 7
Days
3.3%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CLVS, out of 595,212 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CLVS Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
<0.01%
$0.08
Opened
0.02%
$2.41
Increased
0.03%
$1.26
Based on the activity of 11,300 investors who made their portfolios public
The table shows changes in CLVS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CLVS Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Gilead Sciences
4.40%
-0.15%
+0.77%
106.95B
Healthcare
Novavax
4.20%
-0.11%
-0.45%
882.34M
Healthcare
Tilray
4.94%
+0.41%
+0.40%
1.77B
Basic Materials
Crispr Therapeutics AG
3.92%
-0.44%
-0.96%
3.56B
Healthcare
BioNano Genomics
4.43%
-0.54%
-1.15%
478.05M
Healthcare
JD
4.47%
-0.39%
+1.42%
87.41B
Consumer Goods
Bristol Myers
4.09%
-0.66%
-0.66%
155.91B
Healthcare
Canopy Growth
4.27%
-0.01%
+4.22%
1.17B
Basic Materials
General Electric
5.92%
+0.10%
+2.16%
90.67B
Industrial Goods
American Airlines
5.38%
-0.44%
-1.41%
8.47B
Industrial Goods
Based on the activity of 595,212 active portfolios
Open your Smart Portfolio

CLVS Investor Analysis

CLVS investors under 35

Under 35

10.7%
Last 30 days
Holdings Change
21.0%
of CLVS holders
are under 35
Average Segment Performance
Average P/E Ratio12.02
Beta4.79
Dividend Yield4.47%
CLVS investors between 35–55

Between 35–55

3.2%
Last 30 days
Holdings Change
63.0%
of CLVS holders
are between 35–55
Average Segment Performance
Average P/E Ratio9.33
Beta1.07
Dividend Yield5.31%
CLVS investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
15.9%
of CLVS holders
are over 55
Average Segment Performance
Average P/E Ratio9.37
Beta0.87
Dividend Yield4.78%
Overview of age group and performance of CLVS stock investors
See who invests in CLVS according to age group and performance.

FAQ

How many retail Investors hold CLVS?
0.1% of TipRanks' retail investors hold CLVS in their portfolios.
    What is CLVS Investor Sentiment?
    CLVS’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CLVS in the last 7 days?
      ▼ 1.8% of TipRanks' retail investors changed their holding of CLVS in the last 7 days.
        What percentage of retail investors changed their holding of CLVS in the last 30 days?
        ▼ 3.3% of TipRanks' retail investors changed their holding of CLVS in the last 30 days.
          What is the average age of retail investors who hold CLVS?
          The average age of CLVS Holders is between 35–55.
            What other stocks have CLVS investors also bought?
            CLVS Investors also bought GILD, NVAX, TLRY, CRSP, BNGO, JD, BMY, CGC, GE, AAL.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AAgilent
              ALKSAlkermes
              ALNYAlnylam Pharma
              BIOBio-Rad Laboratories
              BSXBoston Scientific
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis